Also categorized in BoardMoves:
Target CEO Gregg Steinhafel Resigns In Data Breach Fallout
x hide permanently

Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors


SAN FRANCISCO, May 06, 2019 (GLOBE NEWSWIRE) --  Adynxx, Inc. (Nasdaq: ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and first-in-class therapeutics for the treatment of pain and inflammatory diseases, today announced the completion of its merger with Alliqua BioMedical, Inc...

Mentions: Nasdaq Merger technology